Samjin Pharm (005500) - Total Liabilities

Latest as of September 2025: ₩184.63 Billion KRW ≈ $125.12 Million USD

Based on the latest financial reports, Samjin Pharm (005500) has total liabilities worth ₩184.63 Billion KRW (≈ $125.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Samjin Pharm - Total Liabilities Trend (2013–2024)

This chart illustrates how Samjin Pharm's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Samjin Pharm to evaluate short-term liquidity relative to the company's equity base.

Samjin Pharm Competitors by Total Liabilities

The table below lists competitors of Samjin Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Panatlântica S.A SA:PATI3	Brazil	R$738.68 Million
Turn Therapeutics Inc. Common Stock NASDAQ:TTRX	USA	$12.53 Million
KG Eco Technology Services Co. Ltd KQ:151860	Korea	₩3.10 Trillion
Ordinary Fully Paid Deferred Settlement AU:BTRDA	Australia	AU$41.10 Million
Intellego Technologies AB ST:INT	Sweden	Skr54.62 Billion
Shanghai Longyun Advg & Media SHG:603729	China	CN¥421.96 Million
Bikurey Hasade Holdings Ltd TA:BKRY	Israel	ILA927.67 Million
Sukgyung AT Co. Ltd. KQ:357550	Korea	₩10.47 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Samjin Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Samjin Pharm market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.70	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samjin Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samjin Pharm (2013–2024)

The table below shows the annual total liabilities of Samjin Pharm from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩163.51 Billion ≈ $110.81 Million	+5.81%
2023-12-31	₩154.54 Billion ≈ $104.73 Million	+18.24%
2022-12-31	₩130.69 Billion ≈ $88.57 Million	+32.92%
2021-12-31	₩98.33 Billion ≈ $66.64 Million	+76.92%
2020-12-31	₩55.58 Billion ≈ $37.66 Million	+19.07%
2019-12-31	₩46.68 Billion ≈ $31.63 Million	+3.84%
2018-12-31	₩44.95 Billion ≈ $30.46 Million	-7.09%
2017-12-31	₩48.38 Billion ≈ $32.79 Million	-16.41%
2016-12-31	₩57.88 Billion ≈ $39.22 Million	-20.36%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-12.72%
2014-12-31	₩83.26 Billion ≈ $56.43 Million	-8.46%
2013-12-31	₩90.96 Billion ≈ $61.64 Million	--

About Samjin Pharm

KO:005500 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$157.08 Million

₩231.79 Billion KRW

Market Cap Rank

#17555 Global

#722 in Korea

Share Price

₩18910.00

Change (1 day)

+0.53%

52-Week Range

₩17240.00 - ₩24700.00

All Time High

₩50479.08